Why you should look at Johnson & Johnson shares?
When it comes to healthcare, it simply doesn't get any bigger than Johnson & Johnson. With a market cap of $343 billion, J&J towers more than $140 billion in market value over the second-largest publicly traded healthcare company, Pfizer. And that growth didn't happen overnight. Since 1970 to the end of March, Johnson & Johnson's stock has increased in value by 11.63%.
Click here to download the presentation slides as a PDF.
Presented by equity analyst, Bianca Haywood.
